MedPath

Pesticides and Parkinson´s Disease

Recruiting
Conditions
Pesticide-Induced Parkinsonism
Interventions
Other: exposure to pesticides
Registration Number
NCT06420310
Lead Sponsor
Hospital Universitario de Burgos
Brief Summary

The aim of this project is to study whether people exposed to pesticides have a higher risk of developing PD. We will perform an epidemiological study determining the presence of pesticides in urine and comparing signs traditionally associated with PD in early forms.

Detailed Description

Within different risk factors, pesticide exposure increases the risk of developing Parkinson's disease (PD) through epigenetic mechanisms by modifying the expression of genes related to PD and secondary mitochondrial dysfunction.We will conduct a cross-sectional prevalence study with cases (exposed to pesticides) and controls (not exposed to pesticides), randomly selecting 130 individuals in each group. Pesticide exposure will be determined through questionnaires.We will study the prevalence of preclinical and prodromal PD based on pesticide exposure, stratified by age and gender in the exposed, and non-exposed groups. Preclinical and prodromal PD will be assessed using: biological biomarkers and prodromal PD signs. Multivariate analyses will be employed to determine the risk of presenting early PD, adjusting for different clinical covariates. The results of this study will allow us to understand the early mechanisms associated with neurodegeneration and pesticides exposure.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
260
Inclusion Criteria
  • Farmers exposed to pesticides for cases
  • No work exposure to pesticides for controls
Exclusion Criteria
  • Subjects without signed consent form
  • Neurological significant conditions

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Casesexposure to pesticidesSubjects exposed to pesticides
Controlsexposure to pesticidesSubjects without any exposure to pesticides
Primary Outcome Measures
NameTimeMethod
Prodromal PDover the last year

Early non motor symptoms

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Universitario de Burgos

🇪🇸

Burgos, Spain

© Copyright 2025. All Rights Reserved by MedPath